Form 10-Q · Quarterly report
Jacobs Solutions 10-Q, filed Aug 4, 2026
- Filed
- CIK
- 0000052988
- Accession no.
- 0001628280-26-052573
Summary
Jacobs Solutions reported revenue of $4.08 billion for the quarter ended June 26, 2026, up from $3.03 billion a year earlier, while net earnings attributable to Jacobs fell to $136.6 million from $179.6 million. The company also acquired full ownership of PA Consulting in March 2026 and continued its "Challenge Accepted" multi-year growth strategy launched in February 2025.
Key points
- Revenue for the quarter ended June 26, 2026 was $4.08 billion versus $3.03 billion in the prior-year quarter.
- Diluted earnings per share from continuing operations were $1.16, down from $1.56 a year earlier; diluted earnings per share overall were $1.15 versus $1.55.
- Jacobs acquired full ownership of PA Consulting in March 2026, making it one of the company's two operating segments alongside Infrastructure & Advanced Facilities.
- Jacobs completed the September 27, 2024 separation of its Critical Mission Solutions and Cyber & Intelligence businesses into Amentum Holdings, which is listed on the NYSE under the symbol AMTM.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Business Overview At Jacobs, our values and our brand promise — Challenging today. Reinventing tomorrow — drive us to deliver innovative solutions and sustainable outcomes for the world’s most complex challenges. With a global team of approximately 47,000, we provide end-to-end capabilities across advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. Our services span strategy and advisory, feasibility and planning, design, program delivery and lifecycle management — helping create a more connected and sustainable world. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.